Literature DB >> 33580459

Increased level of long non coding RNA H19 is correlated with the downregulation of miR-326 and BCL-2 genes in pediatric acute lymphoblastic leukemia, a possible hallmark for leukemogenesis.

Mahtab Mofidi1, Soheila Rahgozar2, Shahrzad Pouyanrad1.   

Abstract

Long non-coding RNAs (lncRNAs) and their role in competitive endogenous RNA (ceRNA) networks have emerged as fundamental debates in the biological processes of initiation and progression of cancer. This study aimed to identify and measure the expression levels of relevant ceRNA regulatory genes contributing to acute lymphoblastic leukemia (ALL). lncRNA H19 and BCL-2 mRNA were chosen based on in silico studies and their interactions with miR-326. Subsequently, the aforementioned coding/non-coding gene expression profiles were measured using qRT-PCR in 50 bone marrow samples, including 33 cases with pediatric ALL and 17 controls with no evidence of malignancy. lncRNA H19 was identified as an oncogenic factor which was noticeably increased in the newly diagnosed patients (P = 0.0019, AUC = 0.84) and negatively associated with miR-326 (r = -0.6, P = 0.02). Furthermore, a negative correlation was introduced between the transcriptional levels of miR-326 and the anti-apoptotic BCL-2 gene (r = -0.6, P = 0.028). The novel experimental and bioinformatic results achieved in this study may provide new insights into the molecular leukemogenesis of pediatric ALL.

Entities:  

Keywords:  BCL-2; Biomarker; Leukemogenesis; Pediatric acute lymphoblastic leukemia; lncRNA H19; miR326

Mesh:

Substances:

Year:  2021        PMID: 33580459     DOI: 10.1007/s11033-021-06161-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  3 in total

1.  Plasma long non-coding RNAs (lncRNAs) serve as potential biomarkers for predicting breast cancer.

Authors:  Z-Y Jiao; Q Tian; N Li; H-B Wang; K-Z Li
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-04       Impact factor: 3.507

Review 2.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

Review 3.  Potential Role of lncRNA H19 as a Cancer Biomarker in Human Cancers Detection and Diagnosis: A Pooled Analysis Based on 1585 Subjects.

Authors:  Yuhan Liu; Anbang He; Baoer Liu; Zhengxian Huang; Hongbing Mei
Journal:  Biomed Res Int       Date:  2019-03-19       Impact factor: 3.411

  3 in total
  4 in total

1.  Exploring the Potential Key IncRNAs with Endometriosis by Construction of a ceRNA Network.

Authors:  Chenglei Gu; Yuanguang Meng; Qingqing Meng; Wensheng Fan; Mingxia Ye; Qian Zhang; Nina Zhang; Lian Li
Journal:  Int J Gen Med       Date:  2021-08-05

Review 2.  Linear and Circular Long Non-Coding RNAs in Acute Lymphoblastic Leukemia: From Pathogenesis to Classification and Treatment.

Authors:  Yasen Maimaitiyiming; Linyan Ye; Tao Yang; Wenjuan Yu; Hua Naranmandura
Journal:  Int J Mol Sci       Date:  2022-04-18       Impact factor: 6.208

3.  lncRNA GAS5 promotes pyroptosis in COPD by functioning as a ceRNA to regulate the miR‑223‑3p/NLRP3 axis.

Authors:  Rubing Mo; Jing Li; Yongxing Chen; Yipeng Ding
Journal:  Mol Med Rep       Date:  2022-05-18       Impact factor: 3.423

Review 4.  Using ncRNAs as Tools in Cancer Diagnosis and Treatment-The Way towards Personalized Medicine to Improve Patients' Health.

Authors:  Roberto Piergentili; Giuseppe Basile; Cristina Nocella; Roberto Carnevale; Enrico Marinelli; Renato Patrone; Simona Zaami
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.